Endometrial cancer, also known as uterine cancer, is defined as an abnormal growth of endometrium cells in the uterus. Market Research Future (MRFR) has published a research report about the global endometrial cancer market that estimates robust growth for this market between 2018 and 2023. The key factors driving this market are changes in sedentary lifestyle, growing consumption of unhealthy diet, growing obesity among women, increase in menopausal hormone therapy, increasing occurrence of Polycystic Ovarian Syndrome (PCOS), increasing prevalence of breast or ovarian tumor, rising prevalence of endometrial cancer, and various socioeconomic factors.
FREE SAMPLE COPY OF “Endometrial Cancer Market Research Report- Global forecast till 2023” @ https://www.marketresearchfuture.com/sample_request/6226
The global endometrial cancer market has been segmented on the basis of diagnosis, end users, treatment, and lastly region. On the basis of diagnosis, this market has been segmented on the basis of dilation & curettage (D&C), diagnostic laparoscopy, endometrial biopsy, pelvic examination, and transvaginal ultrasound. Based on end users, the market has been segmented into ambulatory surgical centers, diagnostic centers, feminist health centers, gynecology centers, and hospitals & clinics.
benefit the doctors in diagnosing and treating their patients.
The global endometrial cancer market can be segmented by diagnosis, treatment, and end-user.
By diagnosis, the market can further be segmented into the pelvic examination, transvaginal ultrasound, endometrial biopsy, dilation and curettage (D&C), and laparoscopy. Endometrial biopsy is very common as the confirmatory test for uterine cancer.
Treatment-based market includes hysterectomy techniques, radiation, hormone therapy, chemotherapy, and palliative care. The hysterectomy techniques category comprises open abdominal hysterectomy, total vaginal hysterectomy, total laparoscopic hysterectomy, and robotic hysterectomy. External radiation and internal radiation (brachytherapy) are part of radiation technology. The hormonal therapy consists progestins, tamoxifen, luteinizing hormone-releasing hormone agonists, and aromatase inhibitors. Chemotherapy can be further sub-segmented into paclitaxel, carboplatin, doxorubicin, and cisplatin and is also the most-used treatment method.
Based on the end-users the market can be segmented into hospitals and clinics, ambulatory surgical centers, diagnostic centers, gynecology centers, feminist health centers, and others.
Region-wise the global endometrial cancer market covers the Americas, Europe, Asia-Pacific (APAC), and the Middle East and Africa (MEA).
The Americas are currently holding the largest market share and can continue to do so in the near future. The region is experiencing a growing number of endometrial patients who are spending much on diagnostic and treatment. The region has a well-structured healthcare system and extensive research units who are also contributing significantly to the regional market.
Europe is currently holding the second position in the market. Robust healthcare sector and advanced technologies are supporting the European market for uterine cancer treatment.
The APAC can also witness significant growth in the market owing to rising incidence of cervical cancer in countries such as India and China.
The market is witnessing significant funding going into research and developments. For instance, Salk Institutes is getting a sizeable amount of fund from Padres Pedal the Cause. Others are mainly focusing on mergers and acquisitions. Royal Philips acquiring EPD Solutions can be taken exemplary. Boston Scientific has also acquired EMcision, Ltd.
The prominent players involved in the market are Pfizer Inc., General Electric Company, Koninklijke Philips N.V., LUPIN, PHYTON, Bayer AG, Celgene Corporation, Johnson & Johnson, CooperSurgical Inc., LiNA Medical USA, Conceptus Inc., Hologic Inc., Karl Storz GmbH & Co. Kg, and Boston Scientific Corporation.
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
OBTAIN RESEARCH REPORT DETAILS WITH TOC @
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar